ArticleFrontiers in oncology2022

Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma.

Mengjie Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.